Neoleukin Therapeutics Announces Clinical Collaboration with Merck to Evaluate NL-201 in Combination with KEYTRUDA® (pembrolizumab)

NEXT STORY
Next Generation Sequencing Market Research Report by Type, by Technology, by Application, by End User, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19
PREV STORY
Acerus Pharmaceuticals Announces Commercial Agreement With Verity Pharmaceuticals for the Promotion of NATESTO® in Puerto Rico
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MAC Clinical Research Announces Presentation at the 60th Annual Scientific Meeting of the American Headache Society

– New clinical trial data highlight potential of an evoked migraine model to test ...

author_avatar
NASDAQ Market News

Medicenna Provides MDNA55 rGBM Clinical Program Update Following Positive End of Phase 2 Meeting with the U.S. Food and Drug Administration (FDA)

author_avatar
NASDAQ Market News

BioXcel Therapeutics Launches “Boiling Point” Educational Campaign to Shed Light on the Importance of Prompt and Cooperative De-escalation in the Acute Treatment of Agitation Associated with Schizophrenia and Bipolar Disorders

author_avatar
NASDAQ Market News